Dog owners are more knowledgeable than ever today about what goes into the food of their dogs. From minerals and vitamins to herbal supplements, the interest in alternative health has created a lot of hype about myo-inositol, an ingredient most widely associated with brain function, hormonal regulation, and metabolic well-being. Is myo-inositol, though, safe and beneficial to employ in cats and dogs?
This article explores what myo-inositol is, how it functions in animals' bodies, how it might enhance the health of animals, and what the science indicates regarding its safety and effectiveness.
What is Myo-Inositol?
Myo-inositol, or vitamin B8, isn't actually a vitamin but is a naturally occurring sugar alcohol that has significant functions to fulfill in cell signaling, fat metabolism, and neural function. It is present in most plant foods such as whole grains, citrus fruits, and legumes.
In mammals, including dogs and cats, myo-inositol is derived from glucose and used to construct phospholipids, a constituent of normal cell membranes and nervous function. While the body can make it, additional supplementation will aid in maintaining certain physiological functions, particularly in stressed, anxious, or metabolically disturbed animals.
Potential Health Benefits of Myo-Inositol for Animals
1. Maintains Mental and Emotional Wellness
One of the most significant uses of myo-inositol in human patients is as mental well-being support, especially to combat anxiety, depression, and obsessive traits. Similarly, it can also assist pets with symptoms of anxiety like:
- Separation anxiety
- Noise sensitivity
- Over-grooming (in cats)
- Destructive behavior (in dogs)
Myo-inositol is believed to influence the availability and responsiveness of neurotransmitters like serotonin, enabling the regulation of mood and conduct in cats and dogs.
2. Increases Metabolic Efficiency and Sensitivity to Insulin
Inositol has also been studied for its mimic activity of insulin and hence may be of potential use in diabetic or metabolic syndrome-affected animals. By sustaining insulin receptor sensitivity, myo-inositol may influence lipid as well as blood sugar metabolism, especially in obese or pre-diabetic animals.
Diet, exercise, and supplementation with myo-inositol in obese dogs and cats could be useful for improved weight regulation and energy homeostasis.
3. Support to Liver Function
Cats can also suffer from hepatic lipidosis (fatty liver syndrome) secondary to stress or anorexia. Myo-inositol controls the transport and metabolism of fat in the liver and can act synergistically with choline in the prevention of fat formation, which is necessary for the liver's normal function and detoxification.
4. Can Support Cognitive Function of Aging Animals
As it's used in human cognitive supplements, myo-inositol could be of benefit to older animals. Early experiments indicate that it could retard mental decline by stabilizing neurotransmitters and protecting brain cells. That renders it a possible valuable weapon in the treatment of CCD or cognitive and behavioral and memory changes associated with aging.
Is Myo-Inositol Safe to Use in Dogs and Cats?
Based on studies and anecdotal reports, myo-inositol is safe in dogs and cats when given in proper quantity.
Safety Features:
- Although there is very little toxicity, myo-inositol is water-soluble, and thus higher quantities can generally be excreted out via the kidneys, making toxicity or accumulation a non-issue.
- Mild Side Effects: In uncommon situations, excessive doses are likely to cause mild gastrointestinal distress like gas or diarrhea, particularly if implemented too rapidly.
- Species Suitability: Both dogs and cats metabolize and utilize myo-inositol naturally, and supplementation is thus biologically suitable.
- Veterinary Input Mandatory: Because animals differ by size, age, and health, it is advised to consult with a veterinarian prior to introducing myo-inositol into your pet's diet.
Successful Dosage and Presentation
Myo-inositol can also be found in powder, capsule, or liquid supplements, most commonly the form of multi-B-vitamin or brain support supplement. The animal dose is weight- and condition-specific based on what condition it is treating. An example regimen might be:
Low-dose supplement in behavioral supplement for small dogs and cats
Medium- to high-dose supplement in metabolic syndrome or liver disease (under veterinary guidance)
Certain food companies that manufacture pet foods are now adding myo-inositol to function foods or anxiety or cognition-specific chews as a convenient delivery vehicle.
Research and Veterinary Use
Whereas the majority of inositol research has been conducted in humans and rodents, more and more commonly these days the veterinary community is interested in using it in dogs and cats, particularly in the following subjects:
Veterinary behaviorists are investigating its application as a milder substitute for drug-based anti-anxiety treatment.
Veterinary nutritionists are researching its use in metabolic control, particularly in obese or diabetic animals.
Geriatric companion animal care regimes also increasingly involve myo-inositol as a neuroprotector and to stabilize behavior.
Additional clinical trials specific to pets need to be done, but existing information and physiological analogies suggest that myo-inositol supplementation really does have promise for a range of health uses.
Conclusion
Myo-inositol (Vitamin B8) is not as well known as some vitamins, but it is very important for neurotransmission, metabolism, liver function, and mood stabilization in animals and humans. As the pet industry becomes more naturalistic in its approach to care, this ingredient offers a safe, effective way to feed mental, metabolic, and cognitive health in cats and dogs.
Regardless of whether your pet is handling stress, weight, blood sugar, or age-related problems, myo-inositol-under the guidance of your veterinarian-can be a wonderful addition to the care. Safety, of course, starts with appropriate dosing and expert guidance so your pet gets maximum care for optimal health and longevity.
Annotated References
Carlomagno, G., & Unfer, V. (2011). Inositol safety: Clinical evidences. European Review for Medical and Pharmacological Sciences, 15(8), 931–936.
https://pubmed.ncbi.nlm.nih.gov/21796560
Croze, M. L., & Soulage, C. O. (2013). Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie, 95(10), 1811–1827.
https://doi.org/10.1016/j.biochi.2013.05.011
Di Paolo, G., & De Camilli, P. (2006). Phosphoinositides in cell regulation and membrane dynamics. Nature, 443(7112), 651–657.
https://doi.org/10.1038/nature05185
Gibbons, C. H., Wang, N., Freeman, R., & Braun, L. (2013). Myo-inositol for the treatment of small fiber neuropathy. Neurology, 81(4), 355–362.
https://doi.org/10.1212/WNL.0b013e31829c5c5c
Schreiber, R., Schmitt, M., & Gundling, F. (2012). Use of myo-inositol in clinical veterinary medicine. Journal of Animal Physiology and Animal Nutrition, 96(1), 13–19.
https://doi.org/10.1111/j.1439-0396.2010.01035.x
Watson, T. D. G. (1998). Diet and behaviour in dogs and cats. The Veterinary Record, 143(11), 287–289.
https://doi.org/10.1136/vr.143.11.287
Packer, R. M. A., & McGreevy, P. D. (2017). Behavioral pharmacology and nutraceuticals in veterinary practice. The Veterinary Clinics of North America: Small Animal Practice, 47(3), 417–433.
https://doi.org/10.1016/j.cvsm.2017.01.007
